SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Tong Zhijun

(Last) (First) (Middle)
18TH FLOOR, JIALONG I NTERNATIONAL
BUILDING, 19 CHAOYANG PARK ROAD

(Street)
BEIJING F4 100125

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
China Biologic Products, Inc. [ CBPO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/04/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock 12/04/2015 M (1) 486 (1) A $9.85 14,486 D
Common stock 12/04/2015 S (1) 486 (1) D $119 14,000 D
Common stock 12/04/2015 M (2) 10,000 (2) A $9.61 24,000 D
Common stock 12/04/2015 S (2) 10,000 (2) D $118 14,000 D
Common stock 12/07/2015 M (3) 4,514 (3) A $9.85 18,514 D
Common stock 12/07/2015 S (3) 4,514 (3) D $119 14,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (4) $9.85 12/04/2015 M 486 09/01/2013 08/31/2022 Common stock 486 (4) 24,514 (6) D
Stock Option (right to buy) (5) $9.61 12/04/2015 M 10,000 10/21/2012 04/20/2022 Common stock 10,000 (5) 14,514 (6) D
Stock Option (right to buy) (4) $9.85 12/07/2015 M 4,514 09/01/2013 08/31/2022 Common stock 4,514 (4) 10,000 (6) D
Explanation of Responses:
1. Represents 486 shares of common stock sold on the open market for $119.00 per share on December 4, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options.
2. Represents 10,000 shares of common stock sold on the open market for $118.00 per share on December 4, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 5 below for further details on the relevant stock options.
3. Represents 4,514 shares of common stock sold on the open market for $119.00 per share on December 7, 2015. These shares of common stock were acquired by the Reporting Person through the cashless exercise of stock options to purchase the Issuer's common stock. See Footnote 4 below for further details on the relevant stock options.
4. Represents previously reported ten year non-qualified stock options to purchase 5,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options vested on September 1, 2013.
5. Represents previously reported stock options to purchase 20,000 shares of the Issuer's common stock, granted pursuant to a stock option agreement dated April 20, 2012. The options vested in two equal tranches on October 21, 2012 and April 21, 2013.
6. Includes the balance of the previously reported stock options as disclosed in Footnotes 4 and 5 above.
/s/ Zhijun Tong 12/08/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.